Decoding Your Diagnosis: The Pathology of Pemphigus Vulgaris
At a Glance
A Pemphigus Vulgaris diagnosis is confirmed using three main tests: an H&E biopsy showing skin cell separation (acantholysis), a DIF test revealing a 'fishnet' pattern of attacking antibodies, and an ELISA blood test measuring specific Dsg1 and Dsg3 antibody levels to track disease activity.
Understanding your pathology report is a powerful step in managing Pemphigus Vulgaris (PV). This document is the definitive “proof” of your diagnosis, detailing the results of three different types of testing: the tissue biopsy (H&E staining), the special immune stain (Direct Immunofluorescence), and the blood test (ELISA).
Decoding the Tissue Biopsy (H&E)
When a pathologist looks at your skin sample under a standard microscope (using Hematoxylin and Eosin, or H&E, stains), they are looking for the physical structure of the blister.
- Acantholysis: This is the hallmark of PV. It describes the way your skin cells have “come apart” or detached from one another [1][2].
- Suprabasal Clefting: This tells the doctor where the skin is coming apart. In PV, the split happens just above the “basal” or bottom layer of the skin [1].
- Row of Tombstones: You may see this poetic but technical phrase in your report. It describes the remaining bottom layer of skin cells that stay attached to the base while the layers above have separated, leaving a row of cells that look like tiny tombstones [1].
The Gold Standard: Direct Immunofluorescence (DIF)
While the H&E biopsy shows that the skin is splitting, the DIF test shows why. This test uses fluorescent dyes to “light up” the autoantibodies that are attacking your skin.
- The “Fishnet” Pattern: In PV, the antibodies (usually IgG and C3) coat the entire surface of the skin cells. When viewed under ultraviolet light, this looks like a glowing lace or “fishnet” pattern [1][3].
- The “Perilesional” Rule: This is critical. For the DIF test to work, the biopsy must be taken from perilesional skin—normal-looking skin about 1 centimeter away from an active sore [3][4].
- False Negatives: If a biopsy is taken from the center of an old blister, the “fishnet” pattern might be destroyed by inflammation, leading to a false-negative result [5]. Similarly, if you have already started high-dose steroids, the antibody signal can become too faint to see [6].
Monitoring with the ELISA Blood Test
The ELISA (Enzyme-Linked Immunosorbent Assay) is a blood test that measures the exact amount of “glue-attacking” antibodies in your system [7].
- Anti-Desmoglein 3 (Dsg3): High levels of this antibody usually mean your mouth and mucous membranes are affected [2][8].
- Anti-Desmoglein 1 (Dsg1): High levels of this antibody, in addition to Dsg3, usually mean you have skin blisters as well [2].
- Tracking Your Progress: Unlike the biopsy, which is usually done once for diagnosis, ELISA tests are often repeated. As you respond to treatment, these numbers should drop, providing an objective way to track your recovery [9][10].
Your Pathology Checklist
An ideal diagnostic report for Pemphigus Vulgaris should include:
- H&E Biopsy findings noting suprabasal acantholysis [1].
- Direct Immunofluorescence (DIF) results showing a “fishnet” or intercellular pattern of IgG [3].
- ELISA results for both Desmoglein 1 and 3 [7].
- Clinical Correlation, meaning the pathologist agrees that the lab results match the symptoms your doctor sees on your body [7].
Next: Understand how these results inform your Road to Remission.
Common questions in this guide
What does "acantholysis" mean on my Pemphigus Vulgaris pathology report?
Why do I need a Direct Immunofluorescence (DIF) test?
What do my ELISA blood test numbers mean?
Can taking steroids affect my Pemphigus Vulgaris biopsy results?
Where should the doctor take the skin biopsy from?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was my biopsy for Direct Immunofluorescence (DIF) taken from 'perilesional' skin, and did it show the classic 'fishnet' pattern of IgG or C3?
- 2.My report mentions 'acantholysis'—is this definitely 'suprabasal' acantholysis, or could it be another type?
- 3.What were my specific numerical ELISA values for anti-desmoglein 1 and 3? How do these numbers compare to the laboratory’s reference range?
- 4.Is there any sign of a secondary infection, like bacteria or yeast, noted in the pathology report that we need to address alongside the PV?
- 5.Since I am already taking steroids, could that have affected the clarity of my immunofluorescence results?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
Current status and prospects for the diagnosis of pemphigus vulgaris.
Nili A, Salehi Farid A, Asgari M, et al.
Expert review of clinical immunology 2021; (17(8)):819-834 doi:10.1080/1744666X.2021.1945925.
PMID: 34162306 - 2
Pemphigus.
Schmidt E, Kasperkiewicz M, Joly P
Lancet (London, England) 2019; (394(10201)):882-894 doi:10.1016/S0140-6736(19)31778-7.
PMID: 31498102 - 3
Pemphigus vulgaris - approach and management.
Popescu IA, Statescu L, Vata D, et al.
Experimental and therapeutic medicine 2019; (18(6)):5056-5060 doi:10.3892/etm.2019.7964.
PMID: 31819769 - 4
Optimal biopsy site for the diagnosis of oral pemphigus vulgaris and mucous membrane pemphigoid: a systematic review and meta-analysis.
Zeng Q, Liu J, Mu J, et al.
International journal of oral and maxillofacial surgery 2023; (52(11)):1162-1172 doi:10.1016/j.ijom.2023.05.005.
PMID: 37268547 - 5
Direct Immunofluorescence of Skin and Oral Mucosa: Guidelines for Selecting the Optimum Biopsy Site.
Mahmood MN
Dermatopathology (Basel, Switzerland) 2024; (11(1)):52-61 doi:10.3390/dermatopathology11010006.
PMID: 38390848 - 6
Clinical Implications of Direct Immunofluorescence Findings in Patients With Ocular Mucous Membrane Pemphigoid.
Labowsky MT, Stinnett SS, Liss J, et al.
American journal of ophthalmology 2017; (183()):48-55 doi:10.1016/j.ajo.2017.08.009.
PMID: 28860044 - 7
[Value of direct immunofluorescence in the diagnosis of oral mucosal pemphigus vulgaris: A retrospective study based on multi-index combined analysis].
Chi Y, Jiang H, Chen Y, et al.
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2026; (58(1)):68-73.
PMID: 41633587 - 8
Detection of anti-desmoglein antibodies in oral lichen planus: What do we know so far.
Didona D, Hertl M
Frontiers in immunology 2022; (13()):1001970 doi:10.3389/fimmu.2022.1001970.
PMID: 36263026 - 9
Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays.
Mortazavi H, Saeidi V, Balighi K, et al.
Iranian journal of allergy, asthma, and immunology 2023; (22(3)):312-318 doi:10.18502/ijaai.v22i3.13059.
PMID: 37524667 - 10
Anti-Desmoglein 3 Avidity Correlates Better With Pemphigus Vulgaris Severity Than Anti-Desmoglein 3 Concentration.
Lekic B, Bonaci-Nikolic B, Lalosevic J, et al.
International journal of dermatology 2026; doi:10.1111/ijd.70322.
PMID: 41670289
This page explains Pemphigus Vulgaris pathology terminology for educational purposes. Your dermatologist and pathologist are the best sources for interpreting your specific biopsy and blood test results.
Get notified when new evidence is published on Pemphigus vulgaris.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.